Results 151 to 160 of about 168,260 (202)

Error in Byline. [PDF]

JAMA Netw Open
europepmc   +1 more source

Immune Network Construction and Prognostic Evaluation of Checkpoint Genes in Endometrial Cancer Using STRING, MCODE, and GEPIA2. [PDF]

Cancer Diagn Progn
Ribeiro DA Costa REA, Zeferino LC, Teixeira JC.   +2 more
europepmc   +1 more source

Proposed modified Brandwein-Gensler histological risk assessment score as prognosticator in oral squamous cell carcinoma. [PDF]

Med Oral Patol Oral Cir Bucal
Sharma D, Gupta S, Koshy G, Kwatra KS, Sharma VK, Kaur A.   +5 more
europepmc   +1 more source

Prediction of tumor-infiltrating lymphocytes through habitat radiomics and exploration of response mechanisms in neoadjuvant immunochemotherapy-treated lung cancer. [PDF]

Cancer Immunol Immunother
Geng Z, Hu Y, Zhou S, Wu G, Gong Z, Feng R, Huang Z, Mei P, Li K, Ye G, Liao Y.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor-Infiltrating Lymphocytes

The Cancer Journal, 2015
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in combination with lymphodepletion and high-dose interleukin 2 has shown reproducible objective response rates of approximately 50% in patients with highly advanced, refractory metastatic melanoma.
Michal J, Besser, Ronnie, Shapira-Frommer, Jacob, Schachter   +2 more
openaire   +3 more sources

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources